N.G. Industries (NGIND) | Financial Analysis & Statements
N.G. Industries Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
37.0M
Gross Profit
28.0M
75.69%
Operating Income
1.9M
5.05%
Net Income
1.9M
5.25%
EPS (Diluted)
₹0.58
Balance Sheet Metrics
Total Assets
414.2M
Total Liabilities
31.0M
Shareholders Equity
385.2M
Debt to Equity
0.08
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
N.G. Industries Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 165.5M | 168.8M | 187.0M | 184.2M | 118.8M |
| Cost of Goods Sold | 42.8M | 43.6M | 68.4M | 65.8M | 32.1M |
| Gross Profit | 122.6M | 125.2M | 118.7M | 118.4M | 86.7M |
| Gross Margin % | 74.1% | 74.2% | 63.4% | 64.3% | 73.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 52.2M | 54.5M | 50.6M | 47.6M | 38.1M |
| Other Operating Expenses | 29.5M | 28.4M | 27.1M | 26.6M | 20.7M |
| Total Operating Expenses | 81.7M | 82.9M | 77.7M | 74.3M | 58.8M |
| Operating Income | 12.7M | 14.2M | 13.6M | 17.9M | 7.7M |
| Operating Margin % | 7.6% | 8.4% | 7.3% | 9.7% | 6.5% |
| Non-Operating Items | |||||
| Interest Income | 1.8M | 1.2M | 905.6K | 1.7M | 1.1M |
| Interest Expense | 525.6K | 171.8K | 206.6K | 164.8K | 209.4K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 91.4M | 58.5M | 96.5M | 33.2M | 8.3M |
| Income Tax | 14.0M | 8.2M | 13.3M | 7.1M | 2.2M |
| Effective Tax Rate % | 15.3% | 14.0% | 13.8% | 21.4% | 26.3% |
| Net Income | 77.4M | 50.3M | 83.2M | 26.1M | 6.1M |
| Net Margin % | 46.8% | 29.8% | 44.5% | 14.2% | 5.2% |
| Key Metrics | |||||
| EBITDA | 27.7M | 27.0M | 22.0M | 26.2M | 13.8M |
| EPS (Basic) | ₹23.10 | ₹15.02 | ₹24.82 | ₹7.79 | ₹1.83 |
| EPS (Diluted) | ₹23.10 | ₹15.02 | ₹24.82 | ₹7.79 | ₹1.83 |
| Basic Shares Outstanding | 3350500 | 3350500 | 3350500 | 3350500 | 3350500 |
| Diluted Shares Outstanding | 3350500 | 3350500 | 3350500 | 3350500 | 3350500 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
N.G. Industries Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 23.2M | 23.5M | 17.2M | 13.9M | 16.3M |
| Short-term Investments | 2.3M | 198.0K | 211.0K | 218.0K | 272.0K |
| Accounts Receivable | 4.3M | 1.5M | 703.5K | 7.8M | 3.3M |
| Inventory | 7.5M | 6.3M | 6.5M | 28.1M | 5.7M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 38.3M | 50.0M | 29.9M | 51.8M | 26.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 131.4M | 142.9M | 137.4M | 136.0M | 130.6M |
| Goodwill | 32.8K | 54.1K | 60.2K | 111.2K | 205.3K |
| Intangible Assets | 32.8K | 54.1K | 60.2K | 111.2K | 205.3K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 375.8M | 349.2M | 277.3M | 219.7M | 144.1M |
| Total Assets | 414.2M | 399.2M | 307.2M | 271.5M | 170.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | - | - | - | 5.2M | 2.8M |
| Short-term Debt | 17.8M | 11.8M | 5.9M | 5.1M | 2.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 4.9M | 3.0M | 10.7M | 9.5M | 16.7M |
| Total Current Liabilities | 31.0M | 37.9M | 25.2M | 32.4M | 28.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 2.9K | 0 | 0 | 0 | -7.9M |
| Total Liabilities | 31.0M | 37.9M | 25.2M | 32.4M | 20.5M |
| Equity | |||||
| Common Stock | 33.5M | 33.5M | 33.5M | 33.5M | 33.5M |
| Retained Earnings | 318.6M | 294.8M | 215.5M | 172.6M | 83.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 385.2M | 361.4M | 282.0M | 239.1M | 150.1M |
| Key Metrics | |||||
| Total Debt | 17.8M | 11.8M | 5.9M | 5.1M | 2.7M |
| Working Capital | 7.3M | 12.2M | 4.7M | 19.4M | -2.0M |
Balance Sheet Composition
N.G. Industries Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 91.4M | 58.5M | 96.5M | 33.2M | 8.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 13.4M | -21.6M | 26.4M | -34.8M | 3.2M |
| Operating Cash Flow | 103.5M | 35.9M | 122.2M | -3.3M | 10.7M |
| Investing Activities | |||||
| Capital Expenditures | 110.0K | 294.5K | 190.0K | 0 | -5.8M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -279.3M | -142.0M | -221.0M | -130.9M | -42.1M |
| Investment Sales | 264.2M | 167.3M | 201.5M | 148.0M | 66.1M |
| Investing Cash Flow | -15.1M | 25.6M | -19.4M | 17.1M | 18.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -11.7M | -11.7M | -11.7M | -53.9K | -102.5K |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | -27.5M |
| Financing Cash Flow | -5.7M | -5.8M | -11.0M | 2.4M | -55.2M |
| Free Cash Flow | 11.5M | -20.7M | 30.0M | -25.2M | 7.7M |
| Net Change in Cash | 82.7M | 55.7M | 91.9M | 16.3M | -26.3M |
Cash Flow Trend
N.G. Industries Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.16
Forward P/E
25.70
Price to Book
1.19
Price to Sales
2.83
PEG Ratio
-0.11
Profitability Ratios
Profit Margin
-8.41%
Operating Margin
8.08%
Return on Equity
20.09%
Return on Assets
18.69%
Financial Health
Current Ratio
1.06
Debt to Equity
2.72
Beta
0.15
Per Share Data
EPS (TTM)
₹-4.14
Book Value per Share
₹117.30
Revenue per Share
₹49.23
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NGIND | 435.1M | 10.16 | 1.19 | 20.09% | -8.41% | 2.72 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Indraprastha Medical | 37.3B | 20.08 | 5.57 | 26.98% | 12.60% | 4.76 |
| Dr. Agarwal's Eye | 24.3B | 34.01 | 7.52 | 26.07% | 15.50% | 106.45 |
| Shalby | 16.7B | 207.28 | 1.75 | 0.63% | 0.72% | 53.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.




